Edesa Biotech Inc — 四半期キャッシュフロー (NASDAQ:EDSA) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

総資産 3.81 M4.16 M16.45 M14.8 M13.53 M14.71 M 負債合計 1.83 M1.9 M914.7 K672.67 K1.08 M756.16 K 純資産合計 1.98 M2.26 M15.54 M14.13 M12.45 M13.95 M 負債および純資産合計 3.81 M4.16 M16.45 M14.8 M13.53 M14.71 M 有利子負債合計 —————— 純負債 ——————

ニュース

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.95%

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.83%

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.76%

Edesa Biotech株、第3相試験の良好なデータで急騰

Edesa Biotech stock surges on positive Phase 3 trial data

Edesa Biotech reports mortality reduction in phase 3 trial

Edesa Biotech、新株発行枠を226万ドルに増額

Edesa Biotech increases at-the-market offering limit to $2.26 million

Edesa Biotech, Inc. (EDSA) Presents at LSX Investival Showcase Europe 2025 - Slideshow (NASDAQ:EDSA) 2025-11-17

エデサ・バイオテック、ARDSの薬剤候補の第3相試験で良好な結果を報告

Edesa’s ARDS drug shows 25% reduction in death risk in phase 3 trial

Edesa Biotech reports positive Phase 3 results for ARDS drug candidate